<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>DailyUpdates from LeadDiscovery: Breaking Research, Development News and Pharmareports for Drug Discovery</title>
<link>http://www.leaddiscovery.co.uk</link>
<description>Dedicated to drug discovery, LeadDiscovery was founded in 1998 by life scientists for life scientists.</description>
<lastBuildDate>Thu, 09 Feb 2012 21:56:55 GMT</lastBuildDate>
<image>
<title>DailyUpdates</title>
<link>http://www.leaddiscovery.co.uk</link>
<description>Breaking Research, Development News and Pharmareports for Drug Discovery</description>
<url>http://www.leaddiscovery.co.uk/dailyupdates_RSS_Icon.gif</url>
<width>144</width>
<height>59</height>
</image>

<item>
<guid>http://www.leaddiscovery.co.uk/articles/22137068/dailyupdate?1</guid>
<link>http://www.leaddiscovery.co.uk/articles/22137068/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction.</title>
<description>Rationale and design of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial: A randomized controlled study of spironolactone in patients with symptomatic heart failure and preserved ejection fraction....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22137068/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/21956443/dailyupdate?2</guid>
<link>http://www.leaddiscovery.co.uk/articles/21956443/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.</title>
<description>Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/21956443/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22030716/dailyupdate?3</guid>
<link>http://www.leaddiscovery.co.uk/articles/22030716/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats.</title>
<description>Blockade of dopamine d4 receptors attenuates reinstatement of extinguished nicotine-seeking behavior in rats....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22030716/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22236931/dailyupdate?4</guid>
<link>http://www.leaddiscovery.co.uk/articles/22236931/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Quitting smoking with varenicline: parallel randomised efficacy trial in Iran.</title>
<description>Quitting smoking with varenicline: parallel randomised efficacy trial in Iran....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22236931/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22119468/dailyupdate?5</guid>
<link>http://www.leaddiscovery.co.uk/articles/22119468/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>() - 2 - (N - tert - Butylamino) - 3 - (125)I - iodo - 4 - azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin Zyban).</title>
<description>() - 2 - (N - tert - Butylamino) - 3 - (125)I - iodo - 4 - azidopropiophenone: A dopamine transporter and nicotinic acetylcholine receptor photoaffinity ligand based on bupropion (Wellbutrin Zyban)....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22119468/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22123706/dailyupdate?6</guid>
<link>http://www.leaddiscovery.co.uk/articles/22123706/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Symptomatic Hyperbilirubinemia Secondary to Dapsone Induced Hemolysis and Atazanavir Therapy.</title>
<description>Symptomatic Hyperbilirubinemia Secondary to Dapsone Induced Hemolysis and Atazanavir Therapy....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22123706/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22137787/dailyupdate?7</guid>
<link>http://www.leaddiscovery.co.uk/articles/22137787/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E(2) synthase - 1 inhibitors.</title>
<description>Synthesis and SAR study of imidazoquinolines as a novel structural class of microsomal prostaglandin E(2) synthase - 1 inhibitors....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22137787/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22137342/dailyupdate?8</guid>
<link>http://www.leaddiscovery.co.uk/articles/22137342/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Discovery and optimization of thieno23 - dpyrimidines as B - Raf inhibitors.</title>
<description>Discovery and optimization of thieno23 - dpyrimidines as B - Raf inhibitors....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22137342/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22123713/dailyupdate?9</guid>
<link>http://www.leaddiscovery.co.uk/articles/22123713/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial.</title>
<description>Does Severe Anemia Caused by Dose-Dense Paclitaxel-Carboplatin Combination Therapy Have an Effect on the Survival of Patients With Epithelial Ovarian Cancer Retrospective Analysis of the Japanese Gynecologic Oncology Group 3016 Trial....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22123713/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22137847/dailyupdate?10</guid>
<link>http://www.leaddiscovery.co.uk/articles/22137847/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>Design and diversity - oriented synthesis of novel 14 - thiazepan - 3 - ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities.</title>
<description>Design and diversity - oriented synthesis of novel 14 - thiazepan - 3 - ones fused with bioactive heterocyclic skeletons and evaluation of their antioxidant and cytotoxic activities....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22137847/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/articles/22124154/dailyupdate?11</guid>
<link>http://www.leaddiscovery.co.uk/articles/22124154/dailyupdate</link>
<pubDate>Thu, 09 Feb 2012 21:56:52 GMT</pubDate>
<title>A Novel Function of p38-RegulatedActivated Kinase (PRAK) In Endothelial Cell Migration and Tumor Angiogenesis.</title>
<description>A Novel Function of p38-RegulatedActivated Kinase (PRAK) In Endothelial Cell Migration and Tumor Angiogenesis....&lt;a href=&quot;http://www.leaddiscovery.co.uk/articles/22124154/dailyupdate&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/news/10065?12</guid>
<link>http://www.leaddiscovery.co.uk/news/10065</link>
<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>
<title>Amgen to Discuss Application for New Use of XGEVA (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting</title>
<description>Amgen to Discuss Application for New Use of XGEVA (denosumab) at FDA Oncologic Drugs Advisory Committee Meeting...&lt;a href=&quot;http://www.leaddiscovery.co.uk/news/10065&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/news/10066?13</guid>
<link>http://www.leaddiscovery.co.uk/news/10066</link>
<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>
<title>Forest Laboratories Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder</title>
<description>Forest Laboratories Inc. and Gedeon Richter Plc Announce Positive Phase III Results with the Investigational Antipsychotic Cariprazine in Patients with Acute Mania Associated with Bipolar I Disorder...&lt;a href=&quot;http://www.leaddiscovery.co.uk/news/10066&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/news/10064?14</guid>
<link>http://www.leaddiscovery.co.uk/news/10064</link>
<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>
<title>BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program</title>
<description>BioSante Pharmaceuticals Reports Positive LibiGel Safety Data Review for Phase III Program...&lt;a href=&quot;http://www.leaddiscovery.co.uk/news/10064&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/news/10063?15</guid>
<link>http://www.leaddiscovery.co.uk/news/10063</link>
<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>
<title>FDA Sets Shortcut Path for Biosimilar Drugs</title>
<description>FDA Sets Shortcut Path for Biosimilar Drugs...&lt;a href=&quot;http://www.leaddiscovery.co.uk/news/10063&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/news/10067?16</guid>
<link>http://www.leaddiscovery.co.uk/news/10067</link>
<pubDate>Thu, 09 Feb 2012 21:56:53 GMT</pubDate>
<title>OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology</title>
<description>OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology...&lt;a href=&quot;http://www.leaddiscovery.co.uk/news/10067&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11111?17</guid>
<link>http://www.leaddiscovery.co.uk/trials/11111</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Nesiritide in Resistant Hypertension</title>
<description>Nesiritide in Resistant Hypertension...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11111&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11105?18</guid>
<link>http://www.leaddiscovery.co.uk/trials/11105</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>A Study to Evaluate the PKPD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment</title>
<description>A Study to Evaluate the PKPD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11105&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11095?19</guid>
<link>http://www.leaddiscovery.co.uk/trials/11095</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1</title>
<description>An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic HCV-1 and HIV-1...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11095&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11093?20</guid>
<link>http://www.leaddiscovery.co.uk/trials/11093</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis</title>
<description>Pharmacokinetics of Vancomycin for Inhalation in Cystic Fibrosis...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11093&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11092?21</guid>
<link>http://www.leaddiscovery.co.uk/trials/11092</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)</title>
<description>A Study of MK-6072 and MK-3415A in Participants Receiving Antibiotic Therapy for Clostridium Difficile Infection (MK-3415A-002)...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11092&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11104?22</guid>
<link>http://www.leaddiscovery.co.uk/trials/11104</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Safety Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis</title>
<description>Safety Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee Osteoarthritis...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11104&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/11106?23</guid>
<link>http://www.leaddiscovery.co.uk/trials/11106</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced andor Metastatic Cancer</title>
<description>Phase I Intratumoral Pbi-shRNA STMN1 LP in Advanced andor Metastatic Cancer...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/11106&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/10179?24</guid>
<link>http://www.leaddiscovery.co.uk/trials/10179</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Safety and PK Study of RRx-001 in Cancer Subjects</title>
<description>Safety and PK Study of RRx-001 in Cancer Subjects...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/10179&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/10172?25</guid>
<link>http://www.leaddiscovery.co.uk/trials/10172</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder</title>
<description>Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/10172&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/trials/10169?26</guid>
<link>http://www.leaddiscovery.co.uk/trials/10169</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors</title>
<description>CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors...&lt;a href=&quot;http://www.leaddiscovery.co.uk/trials/10169&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/reports/2105?27</guid>
<link>http://www.leaddiscovery.co.uk/reports/2105</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>
<description>Psoriasis Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href=&quot;http://www.leaddiscovery.co.uk/reports/2105&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/reports/2106?28</guid>
<link>http://www.leaddiscovery.co.uk/reports/2106</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>
<description>Type 1 Diabetes Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href=&quot;http://www.leaddiscovery.co.uk/reports/2106&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/reports/2108?29</guid>
<link>http://www.leaddiscovery.co.uk/reports/2108</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>
<description>Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href=&quot;http://www.leaddiscovery.co.uk/reports/2108&quot;&gt;Read More&lt;/a&gt;</description>
</item>


<item>
<guid>http://www.leaddiscovery.co.uk/reports/2109?30</guid>
<link>http://www.leaddiscovery.co.uk/reports/2109</link>
<pubDate>Thu, 09 Feb 2012 21:56:54 GMT</pubDate>
<title>Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018</title>
<description>Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018...&lt;a href=&quot;http://www.leaddiscovery.co.uk/reports/2109&quot;&gt;Read More&lt;/a&gt;</description>
</item>

</channel>
</rss>
